Proteoglycans in the central nervous system: Role in development, neural repair, and Alzheimer's disease

IUBMB Life

Volumn 65, Issue 2, 2013, Pages 108-120

  Cui, Hao ^a,b   Freeman, Craig ^c   Jacobson, Glenn A ^b   Small, David H ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c Biology and Environment   (Australia)

Author keywords

Alzheimer's disease; brain development; glycosaminoglycans; proteoglycan

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; BIGLYCAN; CERTOPARIN; CORE PROTEIN; DECORIN; GLYCOSAMINOGLYCAN; HYALURONIC ACID; KERATAN SULFATE; LOW MOLECULAR WEIGHT HEPARIN; NEUROPARIN; OLIGOSACCHARIDE; OLIGOSACCHARIDE C3; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; URONIC ACID;

ALZHEIMER DISEASE; ASTROCYTOSIS; BRAIN INJURY; DEGENERATIVE DISEASE; DRUG STRUCTURE; HUMAN; NERVE CELL PLASTICITY; NERVE FIBER REGENERATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; SYNAPTOGENESIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CENTRAL NERVOUS SYSTEM; CHONDROITIN SULFATE PROTEOGLYCANS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; NEURONAL PLASTICITY; SYNAPSES;

EID: 84873834590     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1118     Document Type: Review

References (187)

1. Hardingham, T. E., and, Fosang, A. J., (1992) Proteoglycans: many forms and many functions. FASEB J. 6, 861-870.
2. Casu, B., (1985) Structure and biological activity of heparin. Adv. Carbohydr. Chem. Biochem. 43, 51-134.
3. Hileman, R. E., Fromm, J. R., Weiler, J. M., and, Linhardt, R. J., (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20, 156-167.
4. Linhardt, R. J., Ampofo, S. A., Fareed, J., Hoppensteadt, D., Mulliken, J. B., et al. (1992) Isolation and characterization of human heparin. Biochemistry 31, 12441-12445.
5. Castillo, G. M., Cummings, J. A., Yang, W., Judge, M. E., Sheardown, M. J., et al. (1998) Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 47, 612-620.
6. Wedemeyer, J., Tsai, M., and, Galli, S. J., (2000) Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12, 624-631.
7. Lindahl, U., Kusche-Gullberg, M., and, Kjellen, L., (1998) Regulated diversity of heparan sulfate. J. Biol. Chem. 273, 24979-24982.
8. Silbert, J. E., and, Sugumaran, G., (2002) Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 54, 177-186.
9. McDonald, J. A., and, Camenisch, T. D., (2002) Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj. J. 19, 331-339.
10. Meyer, K., Linker, A., Davidson, E. A., and, Weissmann, B., (1953) The mucopolysaccharides of bovine cornea. J. Biol. Chem. 205, 611-616.
11. Krusius, T., Finne, J., Margolis, R. K., and, Margolis, R. U., (1986) Identification of an O-glycosidic mannose-linked sialylated tetrasaccharide and keratan sulfate oligosaccharides in the chondroitin sulfate proteoglycan of brain. J. Biol. Chem. 261, 8237-8242.
12. Funderburgh, J. L., (2000) Keratan sulfate: structure, biosynthesis, and function. Glycobiology 10, 951-958.
13. Small, D. H., Mok, S. S., Williamson, T. G., and, Nurcombe, V., (1996) Role of proteoglycans in neural development, regeneration, and the aging brain, J. Neurochem. 67, 889-899.
14. Doege, K. J., Sasaki, M., Kimura, T., and, Yamada, Y., (1991) Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J. Biol. Chem. 266, 894-902.
15. Zimmermann, D. R., and, Ruoslahti, E., (1989) Multiple domains of the large fibroblast proteoglycan. versican, EMBO J. 8, 2975-2981.
16. Rauch, U., Karthikeyan, L., Maurel, P., Margolis, R. U., and, Margolis, R. K., (1992) Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J. Biol. Chem. 267, 19536-19547.
17. Yamada, H., Watanabe, K., Shimonaka, M., and, Yamaguchi, Y., (1994) Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J. Biol. Chem. 269, 10119-10126.
18. Yamaguchi, Y., (2000) Lecticans: organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 57, 276-289.
19. Galtrey, C. M., and, Fawcett, J. W., (2007) The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 54, 1-18.
20. Maurel, P., Rauch, U., Flad, M., Margolis, R. K., and, Margolis, R. U., (1994) Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 91, 2512-2516.
21. Hocking, A. M., Shinomura, T., and, McQuillan, D. J., (1998) Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 17, 1-19.
22. Nishiyama, A., Dahlin, K. J., Prince, J. T., Johnstone, S. R., and, Stallcup, W. B., (1991) The primary structure of NG2, a novel membrane-spanning proteoglycan. J. Cell Biol. 114, 359-371.
23. Staub, E., Hinzmann, B., and, Rosenthal, A., (2002) A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defines a new protein family. FEBS Lett. 527, 114-118.
24. Watanabe, E., Maeda, N., Matsui, F., Kushima, Y., Noda, M., et al. (1995) Neuroglycan C, a novel membrane-spanning chondroitin sulfate proteoglycan that is restricted to the brain. J. Biol. Chem. 270, 26876-26882.
25. Aono, S., Keino, H., Ono, T., Yasuda, Y., Tokita, Y., et al. (2000) Genomic organization and expression pattern of mouse neuroglycan C in the cerebellar development. J. Biol. Chem. 275, 337-342.
26. Shioi, J., Pangalos, M. N., Ripellino, J. A., Vassilacopoulou, D., Mytilineou, C., et al. (1995) The Alzheimer amyloid precursor proteoglycan (appican) is present in brain and is produced by astrocytes but not by neurons in primary neural cultures. J. Biol. Chem. 270, 11839-11844.
27. Pangalos, M. N., Efthimiopoulos, S., Shioi, J., and, Robakis, N. K., (1995) The chondroitin sulfate attachment site of appican is formed by splicing out exon 15 of the amyloid precursor gene. J. Biol. Chem. 270, 10388-10391.
28. Shioi, J., Anderson, J. P., Ripellino, J. A., and, Robakis, N. K., (1992) Chondroitin sulfate proteoglycan form of the Alzheimer's beta-amyloid precursor. J. Biol. Chem. 267, 13819-13822.
29. Dreyfuss, J. L., Regatieri, C. V., Jarrouge, T. R., Cavalheiro, R. P., Sampaio, L. O., et al. (2009) Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. An. Acad. Bras. Cienc. 81, 409-429.
30. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., et al. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8, 365-393.
31. Elenius, K., and, Jalkanen, M., (1994) Function of the syndecans-a family of cell surface proteoglycans. J. Cell Sci. 107 (Pt 11), 2975-2982.
32. David, G., (1993) Integral membrane heparan sulfate proteoglycans. FASEB J. 7, 1023-1030.
33. Schulz, J. G., Annaert, W., Vandekerckhove, J., Zimmermann, P., De Strooper, B., et al. (2003) Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling. J. Biol. Chem. 278, 48651-48657.
34. Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, G., and, Bernfield, M., (2000) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 148, 811-824.
35. Filmus, J., Capurro, M., and, Rast, J., (2008) Glypicans. Genome Biol. 9, 224.
36. De Cat, B., and, David, G., (2001) Developmental roles of the glypicans. Semin. Cell. Dev. Biol. 12, 117-125.
37. De Cat, B., Muyldermans, S. Y., Coomans, C., Degeest, G., Vanderschueren, B., et al. (2003) Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements. J. Cell Biol. 163, 625-635.
38. Iozzo, R. V., Cohen, I. R., Grassel, S., and, Murdoch, A. D., (1994) The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302 (Pt 3), 625-639.
39. Kirn-Safran, C., Farach-Carson, M. C., and, Carson, D. D., (2009) Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell. Mol. Life Sci. 66, 3421-3434.
40. Winzen, U., Cole, G. J., and, Halfter, W., (2003) Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. J. Biol. Chem. 278, 30106-30114.
41. Iozzo, R. V., (2005) Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell. Biol. 6, 646-656.
42. Alliel, P. M., Perin, J. P., Jolles, P., and, Bonnet, F. J., (1993) Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur. J. Biochem. 214, 347-350.
43. Maeda, N., Ishii, M., Nishimura, K., and, Kamimura, K., (2011) Functions of chondroitin sulfate and heparan sulfate in the developing brain. Neurochem. Res. 36, 1228-1240.
44. Properzi, F., and, Fawcett, J. W., (2004) Proteoglycans and brain repair. News Physiol. Sci. 19, 33-38.
45. Carulli, D., Laabs, T., Geller, H. M., and, Fawcett, J. W., (2005) Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 15, 116-120.
46. Meyer-Puttlitz, B., Milev, P., Junker, E., Zimmer, I., Margolis, R. U., et al. (1995) Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan. J. Neurochem. 65, 2327-2337.
47. Perris, R., and, Perissinotto, D., (2000) Role of the extracellular matrix during neural crest cell migration. Mech. Dev. 95, 3-21.
48. Kubota, Y., Morita, T., Kusakabe, M., Sakakura, T., and, Ito, K., (1999) Spatial and temporal changes in chondroitin sulfate distribution in the sclerotome play an essential role in the formation of migration patterns of mouse neural crest cells. Dev. Dyn. 214, 55-65.
49. Perissinotto, D., Iacopetti, P., Bellina, I., Doliana, R., Colombatti, A., et al. (2000) Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development 127, 2823-2842.
50. Landolt, R. M., Vaughan, L., Winterhalter, K. H., and, Zimmermann, D. R., (1995) Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 121, 2303-2312.
51. Oakley, R. A., and, Tosney, K. W., (1991) Peanut agglutinin and chondroitin-6-sulfate are molecular markers for tissues that act as barriers to axon advance in the avian embryo. Dev. Biol. 147, 187-206.
52. Oakley, R. A., Lasky, C. J., Erickson, C. A., and, Tosney, K. W., (1994) Glycoconjugates mark a transient barrier to neural crest migration in the chicken embryo. Development 120, 103-114.
53. Ring, C., Hassell, J., and, Halfter, W., (1996) Expression pattern of collagen IX and potential role in the segmentation of the peripheral nervous system. Dev. Biol. 180, 41-53.
54. Snow, D. M., Lemmon, V., Carrino, D. A., Caplan, A. I., and, Silver, J., (1990) Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 109, 111-130.
55. Fichard, A., Verna, J. M., Olivares, J., and, Saxod, R., (1991) Involvement of a chondroitin sulfate proteoglycan in the avoidance of chick epidermis by dorsal root ganglia fibers: a study using beta-D-xyloside. Dev. Biol. 148, 1-9.
56. Verna, J. M., Fichard, A., and, Saxod, R., (1989) Influence of glycosaminoglycans on neurite morphology and outgrowth patterns in vitro. Int. J. Dev. Neurosci. 7, 389-399.
57. Dou, C. L., and, Levine, J. M., (1994) Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14, 7616-7628.
58. Wang, H., Katagiri, Y., McCann, T. E., Unsworth, E., Goldsmith, P., et al. (2008) Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J. Cell Sci. 121, 3083-3091.
59. Brittis, P. A., Canning, D. R., and, Silver, J., (1992) Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science 255, 733-736.
60. Snow, D. M., Watanabe, M., Letourneau, P. C., and, Silver, J., (1991) A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth. Development 113, 1473-1485.
61. Engel, M., Maurel, P., Margolis, R. U., and, Margolis, R. K., (1996) Chondroitin sulfate proteoglycans in the developing central nervous system. I. Cellular sites of synthesis of neurocan and phosphacan. J. Comp. Neurol. 366, 34-43.
62. Ida, M., Shuo, T., Hirano, K., Tokita, Y., Nakanishi, K., et al. (2006) Identification and functions of chondroitin sulfate in the milieu of neural stem cells. J. Biol. Chem. 281, 5982-5991.
63. Ogawa, T., Hagihara, K., Suzuki, M., and, Yamaguchi, Y., (2001) Brevican in the developing hippocampal fimbria: differential expression in myelinating oligodendrocytes and adult astrocytes suggests a dual role for brevican in central nervous system fiber tract development. J. Comp. Neurol. 432, 285-295.
64. Bekku, Y., Rauch, U., Ninomiya, Y., and, Oohashi, T., (2009) Brevican distinctively assembles extracellular components at the large diameter nodes of Ranvier in the CNS. J. Neurochem. 108, 1266-1276.
65. Holt, C. E., and, Dickson, B. J., (2005) Sugar codes for axons? Neuron 46, 169-172.
66. Wang, L., and, Denburg, J. L., (1992) A role for proteoglycans in the guidance of a subset of pioneer axons in cultured embryos of the cockroach. Neuron 8, 701-714.
67. Gurwitz, D., and, Cunningham, D. D., (1990) Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition. J. Cell. Physiol. 142, 155-162.
68. Small, D. H., Nurcombe, V., Reed, G., Clarris, H., Moir, R., et al. (1994) A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14, 2117-2127.
69. Williamson, T. G., Nurcombe, V., Beyreuther, K., Masters, C. L., and, Small, D. H., (1995) Affinity purification of proteoglycans that bind to the amyloid protein precursor of Alzheimer's disease. J. Neurochem. 65, 2201-2208.
70. Bronner-Fraser, M., and, Lallier, T., (1988) A monoclonal antibody against a laminin-heparan sulfate proteoglycan complex perturbs cranial neural crest migration in vivo. J. Cell Biol. 106, 1321-1329.
71. Walicke, P. A., (1988) Interactions between basic fibroblast growth factor (FGF) and glycosoaminoglycans in promoting neurite outgrowth. Exp. Neurol. 102, 144-148.
72. Walz, A., McFarlane, S., Brickman, Y. G., Nurcombe, V., Bartlett, P. F., et al. (1997) Essential role of heparan sulfates in axon navigation and targeting in the developing visual system. Development 124, 2421-2430.
73. Irie, A., Yates, E. A., Turnbull, J. E., and, Holt, C. E., (2002) Specific heparan sulfate structures involved in retinal axon targeting. Development 129, 61-70.
74. Lee, J. S., von der Hardt, S., Rusch, M. A., Stringer, S. E., Stickney, H. L., et al. (2004) Axon sorting in the optic tract requires HSPG synthesis by ext2 (dackel) and extl3 (boxer). Neuron 44, 947-960.
75. Rhiner, C., Gysi, S., Frohli, E., Hengartner, M. O., and, Hajnal, A., (2005) Syndecan regulates cell migration and axon guidance in C. elegans. Development 132, 4621-4633.
76. Habuchi, H., Kobayashi, M., and, Kimata, K., (1998) Molecular characterization and expression of heparan-sulfate 6-sulfotransferase. Complete cDNA cloning in human and partial cloning in Chinese hamster ovary cells. J. Biol. Chem. 273, 9208-9213.
77. Bai, X., and, Esko, J. D., (1996) An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J. Biol. Chem. 271, 17711-17717.
78. Pratt, T., Conway, C. D., Tian, N. M., Price, D. J., and, Mason, J. O., (2006) Heparan sulphation patterns generated by specific heparan sulfotransferase enzymes direct distinct aspects of retinal axon guidance at the optic chiasm. J. Neurosci. 26, 6911-6923.
79. Rossjohn, J., Cappai, R., Feil, S. C., Henry, A., McKinstry, W. J., et al. (1999) Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat. Struct. Biol. 6, 327-331.
80. Herms, J., Anliker, B., Heber, S., Ring, S., Fuhrmann, M., et al. (2004) Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J. 23, 4106-4115.
81. Small, D. H., Nurcombe, V., Moir, R., Michaelson, S., Monard, D., et al. (1992) Association and release of the amyloid protein precursor of Alzheimer's disease from chick brain extracellular matrix. J. Neurosci. 12, 4143-4150.
82. Narindrasorasak, S., Lowery, D., Gonzalez-DeWhitt, P., Poorman, R. A., Greenberg, B., et al. (1991) High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266, 12878-12883.
83. Narindrasorasak, S., Lowery, D. E., Altman, R. A., Gonzalez-DeWhitt, P. A., Greenberg, B. D., et al. (1992) Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab. Invest. 67, 643-652.
84. Schubert, D., LaCorbiere, M., Saitoh, T., and, Cole, G., (1989) Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate. Proc Natl Acad Sci USA 86, 2066-2069.
85. Schubert, D., Jin, L. W., Saitoh, T., and, Cole, G., (1989) The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion. Neuron 3, 689-694.
86. Clarris, H. J., Cappai, R., Heffernan, D., Beyreuther, K., Masters, C. L., et al. (1997) Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer's disease by deletion mutagenesis and peptide mapping. J. Neurochem. 68, 1164-1172.
87. Mok, S. S., Sberna, G., Heffernan, D., Cappai, R., Galatis, D., et al. (1997) Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's disease. FEBS Lett. 415, 303-307.
88. Williamson, T. G., Mok, S. S., Henry, A., Cappai, R., Lander, A. D., et al. (1996) Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth. J. Biol. Chem. 271, 31215-31221.
89. Ford-Perriss, M., Turner, K., Guimond, S., Apedaile, A., Haubeck, H. D., et al. (2003) Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development. Dev. Dyn. 227, 170-184.
90. McLaughlin, D., Karlsson, F., Tian, N., Pratt, T., Bullock, S. L., et al. (2003) Specific modification of heparan sulphate is required for normal cerebral cortical development. Mech. Dev. 120, 1481-1488.
91. Nitkin, R. M., Smith, M. A., Magill, C., Fallon, J. R., Yao, Y. M., et al. (1987) Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J. Cell Biol. 105, 2471-2478.
92. Reist, N. E., Magill, C., and, McMahan, U. J., (1987) Agrin-like molecules at synaptic sites in normal, denervated, and damaged skeletal muscles. J. Cell Biol. 105, 2457-2469.
93. Herbst, R., and, Burden, S. J., (2000) The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. EMBO J. 19, 67-77.
94. Ferreira, A., (1999) Abnormal synapse formation in agrin-depleted hippocampal neurons. J. Cell Sci. 112 (Pt 24), 4729-4738.
95. Bose, C. M., Qiu, D., Bergamaschi, A., Gravante, B., Bossi, M., et al. (2000) Agrin controls synaptic differentiation in hippocampal neurons. J. Neurosci. 20, 9086-9095.
96. Gingras, J., Rassadi, S., Cooper, E., and, Ferns, M., (2002) Agrin plays an organizing role in the formation of sympathetic synapses. J. Cell. Biol. 158, 1109-1118.
97. Ksiazek, I., Burkhardt, C., Lin, S., Seddik, R., Maj, M., et al. (2007) Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J. Neurosci. 27, 7183-7195.
98. Tournell, C. E., Bergstrom, R. A., and, Ferreira, A., (2006) Progesterone-induced agrin expression in astrocytes modulates glia-neuron interactions leading to synapse formation. Neuroscience 141, 1327-1338.
99. Lin, Y. L., Lei, Y. T., Hong, C. J., and, Hsueh, Y. P., (2007) Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/ VASP pathway. J. Cell Biol. 177, 829-841.
100. Berardi, N., Pizzorusso, T., and, Maffei, L., (2000) Critical periods during sensory development. Curr. Opin. Neurobiol. 10, 138-145.
101. Deepa, S. S., Carulli, D., Galtrey, C., Rhodes, K., Fukuda, J., et al. (2006) Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J. Biol. Chem. 281, 17789-17800.
102. Kwok, J. C., Carulli, D., and, Fawcett, J. W., (2010) In vitro modeling of perineuronal nets: hyaluronan synthase and link protein are necessary for their formation and integrity. J. Neurochem. 114, 1447-1459.
103. Wang, D., and, Fawcett, J., (2012) The perineuronal net and the control of CNS plasticity. Cell Tissue Res. 349, 147-160.
104. Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J. W., et al. (2002) Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298, 1248-1251.
105. McRae, P. A., Rocco, M. M., Kelly, G., Brumberg, J. C., and, Matthews, R. T., (2007) Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J. Neurosci. 27, 5405-5413.
106. Bukalo, O., Schachner, M., and, Dityatev, A., (2001) Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 104, 359-369.
107. Zhou, X. H., Brakebusch, C., Matthies, H., Oohashi, T., Hirsch, E., et al. (2001) Neurocan is dispensable for brain development. Mol. Cell. Biol. 21, 5970-5978.
108. Brakebusch, C., Seidenbecher, C. I., Asztely, F., Rauch, U., Matthies, H., et al. (2002) Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol. Cell. Biol. 22, 7417-7427.
109. Rolls, A., Shechter, R., and, Schwartz, M., (2009) The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 10, 235-241.
110. Davies, S. J., Goucher, D. R., Doller, C., and, Silver, J., (1999) Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 19, 5810-5822.
111. Asher, R. A., Morgenstern, D. A., Moon, L. D., and, Fawcett, J. W., (2001) Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog. Brain Res. 132, 611-619.
112. Levine, J. M., (1994) Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14, 4716-4730.
113. Harris, N. G., Carmichael, S. T., Hovda, D. A., and, Sutton, R. L., (2009) Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited. J. Neurosci. Res. 87, 2937-2950.
114. McKeon, R. J., Hoke, A., and, Silver, J., (1995) Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 136, 32-43.
115. Smith-Thomas, L. C., Stevens, J., Fok-Seang, J., Faissner, A., Rogers, J. H., et al. (1995) Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J. Cell Sci. 108 (Pt 3), 1307-1315.
116. Moon, L. D., Asher, R. A., Rhodes, K. E., and, Fawcett, J. W., (2001) Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4, 465-466.
117. Bradbury, E. J., Moon, L. D., Popat, R. J., King, V. R., Bennett, G. S., et al. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640.
118. Yick, L. W., Cheung, P. T., So, K. F., and, Wu, W., (2003) Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC. Exp. Neurol. 182, 160-168.
119. Moon, L. D., Asher, R. A., Rhodes, K. E., and, Fawcett, J. W., (2002) Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neuroscience 109, 101-117.
120. Iseki, K., Hagino, S., Mori, T., Zhang, Y., Yokoya, S., et al. (2002) Increased syndecan expression by pleiotrophin and FGF receptor-expressing astrocytes in injured brain tissue. Glia 39, 1-9.
121. Hagino, S., Iseki, K., Mori, T., Zhang, Y., Sakai, N., et al. (2003) Expression pattern of glypican-1 mRNA after brain injury in mice. Neurosci. Lett. 349, 29-32.
122. Properzi, F., Lin, R., Kwok, J., Naidu, M., van Kuppevelt, T. H., et al. (2008) Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation. Eur. J. Neurosci. 27, 593-604.
123. Leadbeater, W. E., Gonzalez, A. M., Logaras, N., Berry, M., Turnbull, J. E., et al. (2006) Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex. J. Neurochem. 96, 1189-1200.
124. Hilton, B. J., Lang, B. T., and, Cregg, J. M., (2012) Keratan sulfate proteoglycans in plasticity and recovery after spinal cord injury. J. Neurosci. 32, 4331-4333.
125. Ito, Z., Sakamoto, K., Imagama, S., Matsuyama, Y., Zhang, H., et al. (2010) N-acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. J. Neurosci. 30, 5937-5947.
126. Imagama, S., Sakamoto, K., Tauchi, R., Shinjo, R., Ohgomori, T., et al. (2011) Keratan sulfate restricts neural plasticity after spinal cord injury. J. Neurosci. 31, 17091-17102.
127. Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., et al. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117.
128. Kidd, M., (1964) Alzheimer's Disease-an electron microscopical study. Brain 87, 307-320.
129. Terry, R. D., Gonatas, N. K., and, Weiss, M., (1964) Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44, 269-297.
130. Glenner, G. G., and, Wong, C. W., (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
131. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., et al. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
132. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
133. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
134. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., et al. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
135. Snow, A. D., Mar, H., Nochlin, D., Kimata, K., Kato, M., et al. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
136. Snow, A. D., Mar, H., Nochlin, D., Sekiguchi, R. T., Kimata, K., et al. (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137, 1253-1270.
137. Su, J. H., Cummings, B. J., and, Cotman, C. W., (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51, 801-813.
138. Perlmutter, L. S., Chui, H. C., Saperia, D., and, Athanikar, J., (1990) Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res. 508, 13-19.
139. Snow, A. D., Sekiguchi, R. T., Nochlin, D., Kalaria, R. N., and, Kimata, K., (1994) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am. J. Pathol. 144, 337-347.
140. Verbeek, M. M., Otte-Holler, I., van den Born, J., van den Heuvel, L. P., David, G., et al. (1999) Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am. J. Pathol. 155, 2115-2125.
141. Cotman, S. L., Halfter, W., and, Cole, G. J., (2000) Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol. Cell. Neurosci. 15, 183-198.
142. O'Callaghan, P., Sandwall, E., Li, J. P., Yu, H., Ravid, R., et al. (2008) Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells. Brain Pathol. 18, 548-561.
143. DeWitt, D. A., Silver, J., Canning, D. R., and, Perry, G., (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 121, 149-152.
144. Snow, A. D., Mar, H., Nochlin, D., Kresse, H., and, Wight, T. N., (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytochem. 40, 105-113.
145. van Horssen, J., Otte-Holler, I., David, G., Maat-Schieman, M. L., van den Heuvel, L. P., et al. (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol. 102, 604-614.
146. van Horssen, J., Wilhelmus, M. M., Heljasvaara, R., Pihlajaniemi, T., Wesseling, P., et al. (2002) Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol. 12, 456-462.
147. Shimizu, H., Ghazizadeh, M., Sato, S., Oguro, T., and, Kawanami, O., (2009) Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease. J. Clin. Neurosci. 16, 277-282.
148. Miller, J. D., Cummings, J., Maresh, G. A., Walker, D. G., Castillo, G. M., et al. (1997) Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus. Glia 21, 228-243.
149. Buee, L., Ding, W., Delacourte, A., and, Fillit, H., (1993) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res. 601, 154-163.
150. Buee, L., Ding, W., Anderson, J. P., Narindrasorasak, S., Kisilevsky, R., et al. (1993) Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 627, 199-204.
151. Fraser, P. E., Nguyen, J. T., Chin, D. T., and, Kirschner, D. A., (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540.
152. McLaurin, J., and, Fraser, P. E., (2000) Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. Eur. J. Biochem. 267, 6353-6361.
153. Brunden, K. R., Richter-Cook, N. J., Chaturvedi, N., and, Frederickson, R. C., (1993) pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 2147-2154.
154. Watson, D. J., Lander, A. D., and, Selkoe, D. J., (1997) Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red. J. Biol. Chem. 272, 31617-31624.
155. Castillo, G. M., Ngo, C., Cummings, J., Wight, T. N., and, Snow, A. D., (1997) Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J. Neurochem. 69, 2452-2465.
156. Castillo, G. M., Lukito, W., Wight, T. N., and, Snow, A. D., (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J. Neurochem. 72, 1681-1687.
157. Fraser, P. E., Darabie, A. A., and, McLaurin, J. A., (2001) Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. Implications for drug development. J. Biol. Chem. 276, 6412-6419.
158. Bravo, R., Arimon, M., Valle-Delgado, J. J., Garcia, R., Durany, N., et al. (2008) Sulfated polysaccharides promote the assembly of amyloid beta(1-42) peptide into stable fibrils of reduced cytotoxicity. J. Biol. Chem. 283, 32471-32483.
159. Gupta-Bansal, R., Frederickson, R. C., and, Brunden, K. R., (1995) Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J. Biol. Chem. 270, 18666-18671.
160. Shaffer, L. M., Dority, M. D., Gupta-Bansal, R., Frederickson, R. C., Younkin, S. G., et al. (1995) Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
161. Delacourte, A., and, Defossez, A., (1986) Alzheimer's disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neurol. Sci. 76, 173-186.
162. Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., et al. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553.
163. Perez, M., Valpuesta, J. M., Medina, M., Montejo de Garcini, E., and, Avila, J., (1996) Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J. Neurochem. 67, 1183-1190.
164. Hasegawa, M., Crowther, R. A., Jakes, R., and, Goedert, M., (1997) Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J. Biol. Chem. 272, 33118-33124.
165. Hernandez, F., Perez, M., Lucas, J. J., and, Avila, J., (2002) Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs. Brain Res. 935, 65-72.
166. Paudel, H. K., and, Li, W., (1999) Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping. J. Biol. Chem. 274, 8029-8038.
167. Leveugle, B., Ding, W., Durkin, J. T., Mistretta, S., Eisle, J., et al. (1997) Heparin promotes beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Neurochem. Int. 30, 543-548.
168. Scholefield, Z., Yates, E. A., Wayne, G., Amour, A., McDowell, W., et al. (2003) Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase. J. Cell Biol. 163, 97-107.
169. Patey, S. J., Yates, E. A., and, Turnbull, J. E., (2005) Novel heparan sulphate analogues: inhibition of beta-secretase cleavage of amyloid precursor protein. Biochem. Soc. Trans. 33, 1116-1118.
170. Beckman, M., Holsinger, R. M., and, Small, D. H., (2006) Heparin activates beta-secretase (BACE1) of Alzheimer's disease and increases autocatalysis of the enzyme. Biochemistry 45, 6703-6714.
171. Klaver, D. W., Wilce, M. C., Gasperini, R., Freeman, C., Juliano, J. P., et al. (2010) Glycosaminoglycan-induced activation of the beta-secretase (BACE1) of Alzheimer's disease. J. Neurochem. 112, 1552-1561.
172. Cui, H., Hung, A. C., Klaver, D. W., Suzuki, T., Freeman, C., et al. (2011) Effects of heparin and enoxaparin on APP processing and Abeta production in primary cortical neurons from Tg2576 mice. PLoS One 6, e23007.
173. Cui, H., Hung, A. C., Freeman, C., Narkowicz, C., Jacobson, G. A., et al. (2012) Size and sulfation are critical for the effect of heparin on APP processing and Abeta production. J Neurochem. 123, 447-457.
174. Dudas, B., Rose, M., Cornelli, U., Pavlovich, A., and, Hanin, I., (2008) Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders. Neurodegener. Dis. 5, 200-205.
175. Ma, Q., Dudas, B., Hejna, M., Cornelli, U., Lee, J. M., et al. (2002) The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. Thromb. Res. 105, 447-453.
176. Dudas, B., Cornelli, U., Lee, J. M., Hejna, M. J., Walzer, M., et al. (2002) Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain. Neurobiol. Aging 23, 97-104.
177. Rose, M., Dudas, B., Cornelli, U., and, Hanin, I., (2003) Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats. Neurobiol. Aging 24, 481-490.
178. Rose, M., Dudas, B., Cornelli, U., and, Hanin, I., (2004) Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner. Brain Res. 1015, 96-102.
179. Zhu, H., Yu, J., and, Kindy, M. S., (2001) Inhibition of amyloidosis using low-molecular-weight heparins. Mol. Med. 7, 517-522.
180. Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., et al. (1995) Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat. Med. 1, 143-148.
181. Walzer, M., Lorens, S., Hejna, M., Fareed, J., Hanin, I., et al. (2002) Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology. Eur. J. Pharmacol. 445, 211-220.
182. Bergamaschini, L., Rossi, E., Storini, C., Pizzimenti, S., Distaso, M., et al. (2004) Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease. J. Neurosci. 24, 4181-4186.
183. Timmer, N. M., van Dijk, L., van der Zee, C. E., Kiliaan, A., de Waal, R. M., et al. (2010) Enoxaparin treatment administered at both early and late stages of amyloid beta deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain A beta levels. Neurobiol. Dis. 40, 340-347.
184. Bergamaschini, L., Donarini, C., Rossi, E., De Luigi, A., Vergani, C., et al. (2002) Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-beta in vitro. Neurobiol. Aging 23, 531-536.
185. Sandwall, E., O'Callaghan, P., Zhang, X., Lindahl, U., Lannfelt, L., et al. (2010) Heparan sulfate mediates amyloid-beta internalization and cytotoxicity. Glycobiology 20, 533-541.
186. Kanekiyo, T., Zhang, J., Liu, Q., Liu, C. C., Zhang, L., et al. (2011) Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J. Neurosci. 31, 1644-1651.
187. Leveugle, B., Ding, W., Laurence, F., Dehouck, M. P., Scanameo, A., et al. (1998) Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide. J. Neurochem. 70, 736-744.